Home   


 

 

The ALFERON Access Program™ is a centralized support system developed to make access to ALFERON N Injection® easy. The program is designed to enhance access to ALFERON N Injection® therapy by reducing or eliminating obstacles to distribution, while facilitating reimbursement and providing clinical information.

ALFERON Access Program™

The ALFERON Access Program™ consists of three components:

The individual services are designed to work in collaboration to meet your specific needs.

Connect with the Resource You can learn more about the ALFERON Access Program™ through your Program Customer Service Representative. For questions about the Program, ALFERON N Injection®, or to open an Access account, call toll-free 1-888-ALFERON. For additional information about the Program, you can also contact us via fax at 1-888-FAXX AFN.

What to Expect The ALFERON Access Program™ is staffed from 8:00 a.m. to 7:00 p.m. EST. Representatives are available from each service area to address your specific request. Customer Service Representatives are available to answer questions regarding product distribution and access to ALFERON N Injection®. Also, our Clinical Specialists are on hand to answer technical, product, or clinical questions. In addition, Reimbursement Representatives work to effectively maximize reimbursement.

Distribution Services
Obtaining ALFERON N Injection® is easy once an Access account is established. Product is shipped in an insulated package for receipt on the next business day when requests are received by 4:00 p.m. EST. With most accounts, product is shipped direct; however, the Program provides the flexibility for drop-shipping through a designated wholesaler, when requested.

Clinical and Product Information Services
Professional Clinical Specialists are available to clinicians and patients to answer questions about ALFERON N Injection® -- its administration, proper storage, dosing, number of treatments per vial, and product labeling. Clinical and Product Information Services also serve as an adverse event information reporting center. In addition, published information and literature are available upon request.

Reimbursement Information Services
Reimbursement Representatives provide appropriate ICD-9, CPT, and HCPCS coding designations specific to the use of ALFERON N Injection® to properly code and submit claims to payers. Screening for a patient's insurance eligibility, coverage verification, or payer payment policies is also available. In addition, Reimbursement Representatives can help develop appeal letters, search for available alternative insurance and funding sources, and confirm reimbursement outcomes.


 

Information contained on the Hemispherx website other than historical information, should be considered forward-looking and is subject to various risk factors and uncertainties. For instance, the strategies and operations of Hemispherx involve risks of competition, changing market conditions, changes in laws and regulations affecting these industries and numerous other factors discussed on the Hemispherx website and in the Company's filings with the Securities and Exchange Commission. Accordingly, actual results may differ materially from those in any forward-looking statements. Additionally, all the referenced investigational drugs and associated technologies of the company are experimental in nature and as such are not designated safe and effective by a regulatory authority for general use and are legally available only through clinical trials with the referenced disorders. The forward-looking statements represent the Company's judgement as of the date of this website. The Company disclaims, however, any intent or obligation to update these forward-looking statements.